Novo Nordisk’s amycretin is a single molecule designed to bind to two targets to spark weight loss — a different approach than some of the pharma giant’s other efforts to develop next-generation obesity drugs. Analysts say the lack of details safety and tolerability details make it difficult to fully assess the preliminary Phase 1b/2a results….
January has seen a slew of executive hires, promotions and layoffs across the healthcare industry. For example, health tech companies like Medtronic and athenahealth hired new C-suite leaders, and providers like Cleveland Clinic and Jefferson Health announced rounds of job cuts. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first…
Joseph DeVivo, CEO of portable ultrasound device firm Butterfly Network, led the company’s return to revenue growth in 2024. Now, he wants to have the device be firmly entrenched in hospitals. The post After Getting its “Mojo Back,” What’s Next for Butterfly Network? appeared first on MedCity News.
We now have the ability to diagnose and treat with data-driven insights and deliver measurable outcomes. It’s on us as providers to ensure that we are consistently adopting the latest, proven technology and treatment modalities that can benefit our patients. The post The Keys to Better Mental Healthcare in 2025? Precision, Personalization, and Progress appeared…
Radiotherapy, China’s biotech surge and AI’s role in drug discovery are notable topics that emerged from conversations on the ground floor. The post Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference appeared first on MedCity News.
KFF Health News Southern correspondent Sam Whitehead discussed vaccine exemptions on WAMU’s “Health Hub” on Jan. 22. Whitehead also discussed major Georgia health stories of 2025 on WUGA’s “The Georgia Health Report” on Jan. 17. Click here to hear Whitehead on “Health Hub” Click here to hear Whitehead on “The Georgia Health Report” Read Whitehead’s…
Allara Health’s $26 million Series B raise was led by Index Ventures and included participation from Google Ventures. In total, the company has raised $38.5 million. The post Allara Health Secures $26M to Advance Women’s Hormonal Care appeared first on MedCity News.
The hospital operator will grow its capital budget to about $5.2 billion in 2025.
Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world. The post Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to…
In his return to the White House this week, President Donald Trump issued a flurry of executive orders on immigration, including declaring an emergency at the U.S.-Mexico border, suspending refugee admissions, and calling to roll back birthright citizenship. His administration rescinded a long-standing policy not to arrest people without legal status at or near sensitive…